Abstract
We aimed to evaluate the utility of coagulation markers for the prediction of rapidly progressive interstitial lung disease (RP-ILD) in patients with dermatomyositis (DM). In this retrospective study, 29 patients with DM-associated ILD were analyzed. The number of patients with RP-ILD was 15 (52%). The baseline clinical and demographic data and laboratory markers were analyzed to identify predictive factors for RP-ILD.The univariate logistic regression analysis demonstrated that in addition to well-known laboratory markers, such as serum ferritin, KL-6, and lymphocyte counts, a prolonged activated partial thromboplastin time (aPTT) ratio at the time of DM-associated ILD diagnosis was useful for predicting RP-ILD. Moreover, the logistic regression model and receiver operating characteristic curve analysis showed that combinations of the aPTT ratio and well-known laboratory markers were significantly effective in predicting RP-ILD. This study suggested that an association between RP-ILD and the coagulation system exists.
This is a preview of subscription content, log in via an institution to check access.
References
Johnson C, Pinal-Fernandez I, Parikh R et al (2016) Assessment of mortality in autoimmune myositis with and without associated interstitial lung disease. Lung 194:733–737. https://doi.org/10.1007/s00408-016-9896-x
Sato S, Kuwana M (2010) Clinically amyopathic dermatomyositis. Curr Opin Rheumatol 22:639–643. https://doi.org/10.1097/BOR.0b013e32833f1987
Gono T, Kawaguchi Y, Hara M et al (2010) Increased ferritin predicts development and severity of acute interstitial lung disease as a complication of dermatomyositis. Rheumatology 49:1354–1360. https://doi.org/10.1093/rheumatology/keq073
Xu Y, Yang CS, Li YJ et al (2016) Predictive factors of rapidly progressive-interstitial lung disease in patients with clinically amyopathic dermatomyositis. Clin Rheumatol 35:113–116. https://doi.org/10.1007/s10067-015-3139-z
Kubo H, Nakayama K, Yanai M et al (2005) Anticoagulant therapy for idiopathic pulmonary fibrosis. Chest 128:1475–1482. https://doi.org/10.1378/chest.128.3.1475
Tsushima K, Yamaguchi K, Kono Y et al (2014) Thrombomodulin for acute exacerbations of idiopathic pulmonary fibrosis: A proof of concept study. Pulm Pharmacol Ther 29:233–240. https://doi.org/10.1016/j.pupt.2014.04.008
Ishikawa G, Acquah SO, Salvatore M et al (2017) Elevated serum D-dimer level is associated with an increased risk of acute exacerbation in interstitial lung disease. Respir Med 128:78–84. https://doi.org/10.1016/j.rmed.2017.05.009
Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (first of two parts). N Engl J Med 292:344–347. https://doi.org/10.1056/NEJM197502132920706
Sontheimer RD (2002) Dermatomyositis: an overview of recent progress with emphasis on dermatologic aspects. Dermatol Clin 20:387–408. https://doi.org/10.1016/S0733-8635(02)00021-9
Collard HR, Ryerson CJ, Corte TJ et al (2016) Acute exacerbation of idiopathic pulmonary fibrosis. An International Working Group report. Am J Respir Crit Care Med 194:265–275. https://doi.org/10.1164/rccm.201604-0801CI
Chen F, Wang D, Shu X et al (2012) Anti-MDA5 antibody is associated with A/SIP and decreased T cells in peripheral blood and predicts poor prognosis of ILD in Chinese patients with dermatomyositis. Rheumatol Int 32:3909–3915. https://doi.org/10.1007/s00296-011-2323-y
Tanizawa K, Handa T, Nakashima R et al (2011) HRCT features of interstitial lung disease in dermatomyositis with anti-CADM-140 antibody. Respir Med 105:1380–1387. https://doi.org/10.1016/j.rmed.2011.05.006
Kaarteenaho R, Kinnula VL (2011) Diffuse alveolar damage: a common phenomenon in progressive interstitial lung disorders. Pulm Med 2011:531302. https://doi.org/10.1155/2011/531302
Matthay MA, Ware LB, Zimmerman GA (2012) The acute respiratory distress syndrome. J Clin Invest 122:2731–2740. https://doi.org/10.1172/JCI60331
Funauchi M, Shimadsu H, Tamaki C et al (2006) Role of endothelial damage in the pathogenesis of interstitial pneumonitis in patients with polymyositis and dermatomyositis. J Rheumatol 33:903–906
Winter WE, Flax SD, Harris NS (2017) Coagulation testing in the core laboratory. Lab Med 48:295–313. https://doi.org/10.1093/labmed/lmx050
Cavazzana I, Andreoli L, Limper M et al (2018) Update on antiphospholipid syndrome: ten topics in 2017. Curr Rheumatol Rep 20:15. https://doi.org/10.1007/s11926-018-0718-4
Acknowledgements
We would like to thank Editage (www.editage.jp) for English language editing.
Funding
No specific financial support or other benefits were received for the work described in this manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declared that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Sagawa, T., Kida, T., Inaba, T. et al. Utility of Coagulation Markers for the Prediction of Rapidly Progressive Interstitial Lung Disease in Patients with Dermatomyositis. Lung 197, 437–442 (2019). https://doi.org/10.1007/s00408-019-00245-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00408-019-00245-0